We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

45 hedge funds and large institutions have $3.85M invested in NanoViricides in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

2% more funds holding

Funds holding: 44 → 45 (+1)

0% more ownership

Funds ownership: 0.3% → 0.3% (+0%)

14% less capital invested

Capital invested by funds: $4.49M → $3.85M (-$637K)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$75.7K
2
VF
Virtu Financial
New York
+$45.2K
3
Renaissance Technologies
Renaissance Technologies
New York
+$44.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$44.8K
5
Lido Advisors
Lido Advisors
California
+$16.1K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$16K
2
Goldman Sachs
Goldman Sachs
New York
-$15.8K
3
Group One Trading
Group One Trading
Illinois
-$14K
4
Creative Planning
Creative Planning
Kansas
-$11K
5
TRCT
Tower Research Capital (TRC)
New York
-$9.4K

NNVC Hedge Fund Activity: Q3 2017 in Review

45 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2017, worth a combined $3.85M — down 14% from $4.49M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NNVC positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $75.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $16K sold.

  • 45 institutional investors held NanoViricides (NNVC) as of Q3 2017, up from 44 in Q2 2017.
  • Funds reported $3.85M of NanoViricides stock for Q3 2017, down 14% quarter-over-quarter.
  • 6 funds opened new NanoViricides positions in Q3 2017 and 4 closed out, a net change of +2 holders.
  • The largest NanoViricides buyer in Q3 2017 was Vanguard Group, an estimated $75.7K added.
  • The largest NanoViricides seller in Q3 2017 was Citadel Advisors, an estimated $16K sold.

Based on aggregated 13F filings for Q3 2017.